| Purpose | Patients | Evaluations | Perceived Effectiveness |
|---|---|---|---|
| Pain | 2,786 | 1,030 | |
| Fibromyalgia | 1,575 | 655 | |
| Muscle pain | 695 | 241 | |
| Complex regional pain syndrome type I | 249 | 9 | |
| Complex regional pain syndrome type II | 220 | 13 |
Common side effects
| Side effect | Patients | Percentage |
|---|---|---|
| Constipation | 86 | |
| Nausea | 81 | |
| Drowsiness | 80 | |
| Dry mouth | 61 | |
| Dizziness | 50 | |
| Fatigue | 45 |
Side effect severity
| Severity | Evaluations | Percentage |
|---|---|---|
| Severe | 147 | |
| Moderate | 261 | |
| Mild | 461 | |
| None | 836 |
Member evaluations
bkplus3
evaluated on Mar 11, 2010
- Perceived effectiveness for pain: Can't tell
- Side effects: None
danirae
evaluated on Mar 01, 2010
- Perceived effectiveness for pain: Moderate
- Side effects: Mild
Bramblina
evaluated on Feb 26, 2010
- Perceived effectiveness for breakthrough pain: Moderate
- Side effects: Moderate